5ggq - Revision history

OCA at 11:31, 2 August 2023

OCA — Wed, 02 Aug 2023 11:31:09 GMT

←Older revision		Revision as of 11:31, 2 August 2023
Line 3:		Line 3:
	<StructureSection load='5ggq' size='340' side='right'caption='[[5ggq]], [[Resolution\|resolution]] 1.90Å' scene=''>		<StructureSection load='5ggq' size='340' side='right'caption='[[5ggq]], [[Resolution\|resolution]] 1.90Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5ggq]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5GGQ OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5GGQ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5ggq]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5GGQ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5GGQ FirstGlance]. <br>
-	</td></tr><tr id='~~related~~'><td class="sblockLbl"><b>[[~~Related_structure~~\|~~Related~~:]]</b></td><td class="sblockDat">~~[[5ggv\|5ggv]]~~, [[~~5ggu~~\|~~5ggu]], [[5ggt\|5ggt]], [[5ggs\|5ggs]], [[5ggr\|5ggr~~]]</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.9Å</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5ggq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ggq OCA], [~~http~~://pdbe.org/5ggq PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5ggq RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5ggq PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5ggq ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ggq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ggq OCA], [https://pdbe.org/5ggq PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ggq RCSB], [https://www.ebi.ac.uk/pdbsum/5ggq PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ggq ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 20:		Line 20:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Heo~~, Y S]]~~	+	[[Category: Heo YS]]
-	~~[[Category: Immune system]]~~	+
-	~~[[Category: Therapeutic antibody~~]]	+

OCA at 06:42, 13 May 2020

OCA — Wed, 13 May 2020 06:42:18 GMT

←Older revision		Revision as of 06:42, 13 May 2020
Line 1:		Line 1:

	==Crystal structure of Nivolumab Fab fragment==		==Crystal structure of Nivolumab Fab fragment==
-	<StructureSection load='5ggq' size='340' side='right' caption='[[5ggq]], [[Resolution\|resolution]] 1.90Å' scene=''>	+	<StructureSection load='5ggq' size='340' side='right'caption='[[5ggq]], [[Resolution\|resolution]] 1.90Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5ggq]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5GGQ OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5GGQ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5ggq]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5GGQ OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5GGQ FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5ggv\|5ggv]], [[5ggu\|5ggu]], [[5ggt\|5ggt]], [[5ggs\|5ggs]], [[5ggr\|5ggr]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5ggv\|5ggv]], [[5ggu\|5ggu]], [[5ggt\|5ggt]], [[5ggs\|5ggs]], [[5ggr\|5ggr]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5ggq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ggq OCA], [http://pdbe.org/5ggq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ggq RCSB], [http://www.ebi.ac.uk/pdbsum/5ggq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ggq ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5ggq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ggq OCA], [http://pdbe.org/5ggq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ggq RCSB], [http://www.ebi.ac.uk/pdbsum/5ggq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ggq ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 20:		Line 20:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Heo, Y S]]		[[Category: Heo, Y S]]
	[[Category: Immune system]]		[[Category: Immune system]]
	[[Category: Therapeutic antibody]]		[[Category: Therapeutic antibody]]

OCA at 19:46, 9 December 2016

OCA — Fri, 09 Dec 2016 19:46:55 GMT

←Older revision		Revision as of 19:46, 9 December 2016
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5ggq is ~~ON HOLD until Paper~~ Publication	+	==Crystal structure of Nivolumab Fab fragment==
		+	<StructureSection load='5ggq' size='340' side='right' caption='[[5ggq]], [[Resolution\|resolution]] 1.90Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[5ggq]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5GGQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5GGQ FirstGlance]. <br>
		+	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5ggv\|5ggv]], [[5ggu\|5ggu]], [[5ggt\|5ggt]], [[5ggs\|5ggs]], [[5ggr\|5ggr]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5ggq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ggq OCA], [http://pdbe.org/5ggq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ggq RCSB], [http://www.ebi.ac.uk/pdbsum/5ggq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ggq ProSAT]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Cancer cells express tumour-specific antigens derived via genetic and epigenetic alterations, which may be targeted by T-cell-mediated immune responses. However, cancer cells can avoid immune surveillance by suppressing immunity through activation of specific inhibitory signalling pathways, referred to as immune checkpoints. In recent years, the blockade of checkpoint molecules such as PD-1, PD-L1 and CTLA-4, with monoclonal antibodies has enabled the development of breakthrough therapies in oncology, and four therapeutic antibodies targeting these checkpoint molecules have been approved by the FDA for the treatment of several types of cancer. Here, we report the crystal structures of checkpoint molecules in complex with the Fab fragments of therapeutic antibodies, including PD-1/pembrolizumab, PD-1/nivolumab, PD-L1/BMS-936559 and CTLA-4/tremelimumab. These complex structures elucidate the precise epitopes of the antibodies and the molecular mechanisms underlying checkpoint blockade, providing useful information for the improvement of monoclonal antibodies capable of attenuating checkpoint signalling for the treatment of cancer.

-	~~Authors:~~ Heo, Y.S.	+	Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy.,Lee JY, Lee HT, Shin W, Chae J, Choi J, Kim SH, Lim H, Won Heo T, Park KY, Lee YJ, Ryu SE, Son JY, Lee JU, Heo YS Nat Commun. 2016 Oct 31;7:13354. doi: 10.1038/ncomms13354. PMID:27796306<ref>PMID:27796306</ref>

-	~~Description: Crystal structure~~ of ~~Nivolumab Fab fragment~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased Structures~~]]	+	</div>
-	[[Category: ~~Heo, Y.S~~]]	+	<div class="pdbe-citations 5ggq" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Heo, Y S]]
		+	[[Category: Immune system]]
		+	[[Category: Therapeutic antibody]]

OCA at 21:31, 12 July 2016

OCA — Tue, 12 Jul 2016 21:31:57 GMT

←Older revision		Revision as of 21:31, 12 July 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5ggq is ON HOLD	+	The entry 5ggq is ON HOLD until Paper Publication

	Authors: Heo, Y.S.		Authors: Heo, Y.S.

-	Description: Nivolumab Fab fragment	+	Description: Crystal structure of Nivolumab Fab fragment
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
	[[Category: Heo, Y.S]]		[[Category: Heo, Y.S]]

OCA: Protected "5ggq" [edit=sysop:move=sysop]

OCA — Thu, 23 Jun 2016 18:42:00 GMT

Protected "5ggq" [edit=sysop:move=sysop]

←Older revision

Revision as of 18:42, 23 June 2016

OCA: New page: '''Unreleased structure''' The entry 5ggq is ON HOLD Authors: Heo, Y.S. Description: Nivolumab Fab fragment Category: Unreleased Structures Category: Heo, Y.S

OCA — Thu, 23 Jun 2016 18:41:59 GMT

New page: '''Unreleased structure''' The entry 5ggq is ON HOLD Authors: Heo, Y.S. Description: Nivolumab Fab fragment Category: Unreleased Structures Category: Heo, Y.S

New page

'''Unreleased structure'''

The entry 5ggq is ON HOLD

Authors: Heo, Y.S.

Description: Nivolumab Fab fragment
[[Category: Unreleased Structures]]
[[Category: Heo, Y.S]]